NO20062316L - Nye CXCL8 antagonister - Google Patents

Nye CXCL8 antagonister

Info

Publication number: NO20062316L
Authority: NO; Norway
Prior art keywords: cxcl8; new; antagonists; cxcl8 antagonists; cxcl
Prior art date: 2003-10-22

Application number

NO20062316A

Other languages

English (en)

Norwegian (no)

Inventor

Amanda Proudfoot

Jeffrey Shaw

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-22

Filing date

2006-05-22

Publication date

2006-06-23

2006-05-22 Application filed by Applied Research Systems filed Critical Applied Research Systems

2006-06-23 Publication of NO20062316L publication Critical patent/NO20062316L/no

Links

101001055222 Homo sapiens Interleukin-8 Proteins 0.000 title abstract 2
102100026236 Interleukin-8 Human genes 0.000 title abstract 2
239000005557 antagonist Substances 0.000 title abstract 2
102000004890 Interleukin-8 Human genes 0.000 abstract 2
108090001007 Interleukin-8 Proteins 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 1
210000004899 c-terminal region Anatomy 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 abstract 1
229940096397 interleukin-8 Drugs 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5421—IL-8
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Immunology (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO20062316A 2003-10-22 2006-05-22 Nye CXCL8 antagonister NO20062316L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03103909		2003-10-22
PCT/EP2004/052637 WO2005040210A2 (en)	2003-10-22	2004-10-22	Novel cxcl8 antagonists

Publications (1)

Publication Number	Publication Date
NO20062316L true NO20062316L (no)	2006-06-23

Family

ID=34486342

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20062316A NO20062316L (no)	2003-10-22	2006-05-22	Nye CXCL8 antagonister

Country Status (10)

Country	Link
US (1)	US20090022657A1 (de)
EP (1)	EP1673388B1 (de)
JP (1)	JP2007533300A (de)
AT (1)	ATE415420T1 (de)
AU (1)	AU2004283910A1 (de)
CA (1)	CA2534828A1 (de)
DE (1)	DE602004018014D1 (de)
IL (1)	IL175019A0 (de)
NO (1)	NO20062316L (de)
WO (1)	WO2005040210A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2583852B (en) *	2018-01-18	2022-12-21	Third Wave Bioactives Llc	Fruit and vegetable-based fermentate compositions and methods of making and using the same
TR201811689A2 (tr) *	2018-08-10	2018-09-21	Hacettepe Ueniversitesi	Cxcl8 ami̇no ucu öncül di̇zi̇si̇nden türevlenen i̇mmünmodülatör pepti̇t

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE169638T1 (de) *	1991-12-04	1998-08-15	Biomedical Res Centre Ltd	Analoge des menschlichen interleukin-8.
WO1996009062A1 (en) *	1994-09-23	1996-03-28	University Of Nebraska Board Of Regents	Polypeptide agonists and antagonists of human interleukin-8
UA77950C2 (en) *	2000-10-04	2007-02-15	Applied Research Systems	Use of mutants of cc chemokines for treatment of multiple sclerosis

2004
- 2004-10-22 AU AU2004283910A patent/AU2004283910A1/en not_active Abandoned
- 2004-10-22 WO PCT/EP2004/052637 patent/WO2005040210A2/en not_active Ceased
- 2004-10-22 EP EP04791294A patent/EP1673388B1/de not_active Expired - Lifetime
- 2004-10-22 US US10/573,726 patent/US20090022657A1/en not_active Abandoned
- 2004-10-22 JP JP2006536095A patent/JP2007533300A/ja active Pending
- 2004-10-22 DE DE602004018014T patent/DE602004018014D1/de not_active Expired - Fee Related
- 2004-10-22 CA CA002534828A patent/CA2534828A1/en not_active Abandoned
- 2004-10-22 AT AT04791294T patent/ATE415420T1/de not_active IP Right Cessation
2006
- 2006-04-20 IL IL175019A patent/IL175019A0/en unknown
- 2006-05-22 NO NO20062316A patent/NO20062316L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1673388B1 (de)	2008-11-26
US20090022657A1 (en)	2009-01-22
DE602004018014D1 (de)	2009-01-08
IL175019A0 (en)	2006-08-20
CA2534828A1 (en)	2005-05-06
WO2005040210A3 (en)	2005-06-23
ATE415420T1 (de)	2008-12-15
WO2005040210A2 (en)	2005-05-06
JP2007533300A (ja)	2007-11-22
EP1673388A2 (de)	2006-06-28
AU2004283910A1 (en)	2005-05-06

Similar Documents

Publication	Publication Date	Title
ATE548363T1 (de)	2012-03-15	3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
ATE451376T1 (de)	2009-12-15	Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE446313T1 (de)	2009-11-15	Muteine von tränen-lipocalin
DE602004014117D1 (de)	2008-07-10	Thiazole zur verwendung als inhibitoren von protein-kinasen
ATE433973T1 (de)	2009-07-15	Azolylaminoazine als inhibitoren von proteinkinasen
EP1796669A4 (de)	2009-08-19	Aminopiperidine als dipeptidylpeptidase-iv-inhibitoren zur behandlung oder prävention von diabetes
ATE482213T1 (de)	2010-10-15	Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
ATE466580T1 (de)	2010-05-15	Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de)	2010-06-15	Azolylaminoazine als proteinkinasehemmer
ATE365733T1 (de)	2007-07-15	Zusammensetzungen brauchbar als protein-kinase- inhibitoren
NO20084652L (no)	2008-12-03	Deazapuriner anvendelige som inhibitorer av januskinaser
NO20082476L (no)	2008-06-24	Bicykliske forbindelser med kinaseinhiberende aktivitet
DE602006004844D1 (de)	2009-03-05	Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
ATE528302T1 (de)	2011-10-15	3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin- kinasen nützlich sind
MXPA06011327A (es)	2006-12-15	Azaindoles utiles como inhibidores de jak y otras proteinas cinasas.
NO20054769L (no)	2006-01-03	Substituerte fenylalkansyrer
EP1673078A4 (de)	2007-04-18	Benzylether- und benzylamino-beta-sekretase-hemmer zur behandlung von alzheimer-krankheit
NO20070489L (no)	2007-03-07	3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
EA200501710A1 (ru)	2006-06-30	Замещённые карбоновые кислоты
DE602004024374D1 (de)	2010-01-14	Zusammensetzungen zur verwendung als protein-kinase-inhibitoren
ATE506951T1 (de)	2011-05-15	Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
ATE389651T1 (de)	2008-04-15	Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
MXPA05009014A (es)	2005-10-18	Antagonistas del receptor ccr-3.
DE602006017574D1 (de)	2010-11-25	Als protein-kinase-inhibitoren nutzbare benzimidazole
ATE402958T1 (de)	2008-08-15	Antagonisten des ige-rezeptors

Legal Events

Date	Code	Title	Description
2008-01-14	CREP	Change of representative	Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS
2010-05-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application